nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—CA5B—coronary artery disease	0.31	0.891	CbGaD
Furosemide—ALB—coronary artery disease	0.038	0.109	CbGaD
Furosemide—ABCC2—Olmesartan—coronary artery disease	0.0289	0.0771	CbGbCtD
Furosemide—SLC22A11—Pravastatin—coronary artery disease	0.028	0.0747	CbGbCtD
Furosemide—SLC22A5—Niacin—coronary artery disease	0.0258	0.0687	CbGbCtD
Furosemide—ABCC2—Pitavastatin—coronary artery disease	0.0231	0.0617	CbGbCtD
Furosemide—ABCC2—Telmisartan—coronary artery disease	0.0231	0.0617	CbGbCtD
Furosemide—SLC22A8—Enalapril—coronary artery disease	0.023	0.0614	CbGbCtD
Furosemide—ABCC2—Ezetimibe—coronary artery disease	0.0171	0.0455	CbGbCtD
Furosemide—SLC22A8—Pravastatin—coronary artery disease	0.0163	0.0434	CbGbCtD
Furosemide—SLC22A6—Enalapril—coronary artery disease	0.0161	0.0428	CbGbCtD
Furosemide—ABCC2—Simvastatin—coronary artery disease	0.0159	0.0423	CbGbCtD
Furosemide—ABCC2—Lovastatin—coronary artery disease	0.0155	0.0414	CbGbCtD
Furosemide—ABCC2—Pravastatin—coronary artery disease	0.0155	0.0414	CbGbCtD
Furosemide—ALB—Pitavastatin—coronary artery disease	0.0144	0.0384	CbGbCtD
Furosemide—ABCC2—Atorvastatin—coronary artery disease	0.0141	0.0377	CbGbCtD
Furosemide—ALB—Valsartan—coronary artery disease	0.014	0.0374	CbGbCtD
Furosemide—CA5B—cervicothoracic ganglion—coronary artery disease	0.0127	0.334	CbGeAlD
Furosemide—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.0122	0.0324	CbGbCtD
Furosemide—SLC22A6—Captopril—coronary artery disease	0.012	0.032	CbGbCtD
Furosemide—SLC22A6—Pravastatin—coronary artery disease	0.0114	0.0303	CbGbCtD
Furosemide—ALB—Rosuvastatin—coronary artery disease	0.0106	0.0283	CbGbCtD
Furosemide—ALB—Acetylsalicylic acid—coronary artery disease	0.0104	0.0276	CbGbCtD
Furosemide—ALB—Captopril—coronary artery disease	0.0102	0.0273	CbGbCtD
Furosemide—SLC22A6—Losartan—coronary artery disease	0.00946	0.0252	CbGbCtD
Furosemide—CA5B—sinoatrial node—coronary artery disease	0.00817	0.215	CbGeAlD
Furosemide—ALB—Losartan—coronary artery disease	0.00806	0.0215	CbGbCtD
Furosemide—Indapamide—CA5B—coronary artery disease	0.00119	0.34	CrCbGaD
Furosemide—Bumetanide—CFTR—coronary artery disease	0.00112	0.32	CrCbGaD
Furosemide—Bumetanide—CA5B—coronary artery disease	0.00105	0.299	CrCbGaD
Furosemide—CA14—cardiac ventricle—coronary artery disease	0.00104	0.0273	CbGeAlD
Furosemide—SLCO2A1—cardiac ventricle—coronary artery disease	0.000859	0.0226	CbGeAlD
Furosemide—SLCO2A1—myocardium—coronary artery disease	0.000808	0.0213	CbGeAlD
Furosemide—PGD—myocardium—coronary artery disease	0.000721	0.019	CbGeAlD
Furosemide—CA14—heart—coronary artery disease	0.000681	0.0179	CbGeAlD
Furosemide—CA14—cardiac atrium—coronary artery disease	0.000582	0.0153	CbGeAlD
Furosemide—SLCO2A1—heart—coronary artery disease	0.000564	0.0149	CbGeAlD
Furosemide—PGD—heart—coronary artery disease	0.000503	0.0133	CbGeAlD
Furosemide—CA4—cardiac ventricle—coronary artery disease	0.000501	0.0132	CbGeAlD
Furosemide—SLCO2A1—cardiac atrium—coronary artery disease	0.000483	0.0127	CbGeAlD
Furosemide—CA5B—heart—coronary artery disease	0.000476	0.0126	CbGeAlD
Furosemide—PGD—cardiovascular system—coronary artery disease	0.000475	0.0125	CbGeAlD
Furosemide—CA4—myocardium—coronary artery disease	0.000471	0.0124	CbGeAlD
Furosemide—SLC12A1—blood—coronary artery disease	0.000456	0.012	CbGeAlD
Furosemide—CA5B—cardiovascular system—coronary artery disease	0.00045	0.0118	CbGeAlD
Furosemide—PGD—cardiac atrium—coronary artery disease	0.00043	0.0113	CbGeAlD
Furosemide—CA1—heart—coronary artery disease	0.000421	0.0111	CbGeAlD
Furosemide—CA2—cardiac ventricle—coronary artery disease	0.000415	0.0109	CbGeAlD
Furosemide—SLC22A5—cardiac ventricle—coronary artery disease	0.000409	0.0108	CbGeAlD
Furosemide—CA5B—cardiac atrium—coronary artery disease	0.000407	0.0107	CbGeAlD
Furosemide—CA1—cardiovascular system—coronary artery disease	0.000397	0.0105	CbGeAlD
Furosemide—CA2—myocardium—coronary artery disease	0.000391	0.0103	CbGeAlD
Furosemide—SLC22A5—myocardium—coronary artery disease	0.000384	0.0101	CbGeAlD
Furosemide—PGD—blood—coronary artery disease	0.000375	0.00989	CbGeAlD
Furosemide—ALB—heart—coronary artery disease	0.00037	0.00974	CbGeAlD
Furosemide—CA5B—blood—coronary artery disease	0.000356	0.00937	CbGeAlD
Furosemide—CA4—heart—coronary artery disease	0.000329	0.00867	CbGeAlD
Furosemide—CA1—blood—coronary artery disease	0.000314	0.00827	CbGeAlD
Furosemide—CA4—cardiovascular system—coronary artery disease	0.00031	0.00818	CbGeAlD
Furosemide—CA4—cardiac atrium—coronary artery disease	0.000281	0.00741	CbGeAlD
Furosemide—CA2—heart—coronary artery disease	0.000273	0.00719	CbGeAlD
Furosemide—SLC22A5—heart—coronary artery disease	0.000268	0.00707	CbGeAlD
Furosemide—SLC22A8—blood—coronary artery disease	0.000265	0.00698	CbGeAlD
Furosemide—ABCC2—blood—coronary artery disease	0.000258	0.00681	CbGeAlD
Furosemide—CA2—cardiovascular system—coronary artery disease	0.000257	0.00678	CbGeAlD
Furosemide—CA4—blood—coronary artery disease	0.000245	0.00647	CbGeAlD
Furosemide—CA2—cardiac atrium—coronary artery disease	0.000233	0.00615	CbGeAlD
Furosemide—SLC22A5—cardiac atrium—coronary artery disease	0.000229	0.00605	CbGeAlD
Furosemide—CA2—blood—coronary artery disease	0.000203	0.00536	CbGeAlD
Furosemide—SLC22A5—blood—coronary artery disease	0.0002	0.00528	CbGeAlD
Furosemide—Bumetanide—PTGS2—coronary artery disease	0.000144	0.041	CrCbGaD
Furosemide—Feeling abnormal—Captopril—coronary artery disease	5.23e-05	0.000354	CcSEcCtD
Furosemide—Rash—Fenofibrate—coronary artery disease	5.22e-05	0.000354	CcSEcCtD
Furosemide—Dermatitis—Fenofibrate—coronary artery disease	5.21e-05	0.000353	CcSEcCtD
Furosemide—Headache—Fenofibrate—coronary artery disease	5.19e-05	0.000352	CcSEcCtD
Furosemide—Vision blurred—Lisinopril—coronary artery disease	5.19e-05	0.000352	CcSEcCtD
Furosemide—Paraesthesia—Losartan—coronary artery disease	5.19e-05	0.000351	CcSEcCtD
Furosemide—Gastrointestinal pain—Captopril—coronary artery disease	5.19e-05	0.000351	CcSEcCtD
Furosemide—Urticaria—Telmisartan—coronary artery disease	5.18e-05	0.000351	CcSEcCtD
Furosemide—Vomiting—Clopidogrel—coronary artery disease	5.17e-05	0.000351	CcSEcCtD
Furosemide—Diarrhoea—Simvastatin—coronary artery disease	5.17e-05	0.000351	CcSEcCtD
Furosemide—Body temperature increased—Telmisartan—coronary artery disease	5.15e-05	0.000349	CcSEcCtD
Furosemide—Abdominal pain—Telmisartan—coronary artery disease	5.15e-05	0.000349	CcSEcCtD
Furosemide—Vomiting—Lovastatin—coronary artery disease	5.14e-05	0.000348	CcSEcCtD
Furosemide—Somnolence—Losartan—coronary artery disease	5.13e-05	0.000348	CcSEcCtD
Furosemide—Dizziness—Eplerenone—coronary artery disease	5.13e-05	0.000348	CcSEcCtD
Furosemide—Rash—Clopidogrel—coronary artery disease	5.13e-05	0.000348	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	5.13e-05	0.000348	CcSEcCtD
Furosemide—Dermatitis—Clopidogrel—coronary artery disease	5.13e-05	0.000347	CcSEcCtD
Furosemide—Asthenia—Valsartan—coronary artery disease	5.12e-05	0.000347	CcSEcCtD
Furosemide—Hypersensitivity—Niacin—coronary artery disease	5.11e-05	0.000347	CcSEcCtD
Furosemide—Asthenia—Olmesartan—coronary artery disease	5.1e-05	0.000346	CcSEcCtD
Furosemide—Headache—Clopidogrel—coronary artery disease	5.1e-05	0.000346	CcSEcCtD
Furosemide—Rash—Lovastatin—coronary artery disease	5.1e-05	0.000345	CcSEcCtD
Furosemide—Dermatitis—Lovastatin—coronary artery disease	5.09e-05	0.000345	CcSEcCtD
Furosemide—Anaemia—Lisinopril—coronary artery disease	5.09e-05	0.000345	CcSEcCtD
Furosemide—Feeling abnormal—Perindopril—coronary artery disease	5.07e-05	0.000344	CcSEcCtD
Furosemide—Headache—Lovastatin—coronary artery disease	5.06e-05	0.000343	CcSEcCtD
Furosemide—Pruritus—Valsartan—coronary artery disease	5.05e-05	0.000342	CcSEcCtD
Furosemide—Dry mouth—Ramipril—coronary artery disease	5.05e-05	0.000342	CcSEcCtD
Furosemide—Vomiting—Ezetimibe—coronary artery disease	5.04e-05	0.000342	CcSEcCtD
Furosemide—Hypersensitivity—Pravastatin—coronary artery disease	5.04e-05	0.000341	CcSEcCtD
Furosemide—Gastrointestinal pain—Perindopril—coronary artery disease	5.03e-05	0.000341	CcSEcCtD
Furosemide—Pruritus—Olmesartan—coronary artery disease	5.03e-05	0.000341	CcSEcCtD
Furosemide—Decreased appetite—Losartan—coronary artery disease	5.02e-05	0.00034	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.01e-05	0.00034	CcSEcCtD
Furosemide—Body temperature increased—Captopril—coronary artery disease	5.01e-05	0.00034	CcSEcCtD
Furosemide—Abdominal pain—Captopril—coronary artery disease	5.01e-05	0.00034	CcSEcCtD
Furosemide—Dizziness—Simvastatin—coronary artery disease	5e-05	0.000339	CcSEcCtD
Furosemide—Rash—Ezetimibe—coronary artery disease	5e-05	0.000339	CcSEcCtD
Furosemide—Dermatitis—Ezetimibe—coronary artery disease	4.99e-05	0.000339	CcSEcCtD
Furosemide—Confusional state—Ramipril—coronary artery disease	4.99e-05	0.000338	CcSEcCtD
Furosemide—Asthenia—Niacin—coronary artery disease	4.98e-05	0.000338	CcSEcCtD
Furosemide—Fatigue—Losartan—coronary artery disease	4.98e-05	0.000337	CcSEcCtD
Furosemide—Headache—Ezetimibe—coronary artery disease	4.97e-05	0.000337	CcSEcCtD
Furosemide—Anaphylactic shock—Ramipril—coronary artery disease	4.95e-05	0.000336	CcSEcCtD
Furosemide—Vertigo—Lisinopril—coronary artery disease	4.94e-05	0.000335	CcSEcCtD
Furosemide—Dry mouth—Timolol—coronary artery disease	4.94e-05	0.000335	CcSEcCtD
Furosemide—Constipation—Losartan—coronary artery disease	4.94e-05	0.000335	CcSEcCtD
Furosemide—Pain—Losartan—coronary artery disease	4.94e-05	0.000335	CcSEcCtD
Furosemide—Vomiting—Eplerenone—coronary artery disease	4.93e-05	0.000334	CcSEcCtD
Furosemide—Leukopenia—Lisinopril—coronary artery disease	4.93e-05	0.000334	CcSEcCtD
Furosemide—Nausea—Fenofibrate—coronary artery disease	4.92e-05	0.000333	CcSEcCtD
Furosemide—Pruritus—Niacin—coronary artery disease	4.91e-05	0.000333	CcSEcCtD
Furosemide—Asthenia—Pravastatin—coronary artery disease	4.9e-05	0.000332	CcSEcCtD
Furosemide—Rash—Eplerenone—coronary artery disease	4.89e-05	0.000332	CcSEcCtD
Furosemide—Urticaria—Perindopril—coronary artery disease	4.89e-05	0.000332	CcSEcCtD
Furosemide—Hypersensitivity—Trandolapril—coronary artery disease	4.89e-05	0.000332	CcSEcCtD
Furosemide—Dermatitis—Eplerenone—coronary artery disease	4.89e-05	0.000331	CcSEcCtD
Furosemide—Diarrhoea—Valsartan—coronary artery disease	4.89e-05	0.000331	CcSEcCtD
Furosemide—Confusional state—Timolol—coronary artery disease	4.88e-05	0.000331	CcSEcCtD
Furosemide—Shock—Ramipril—coronary artery disease	4.87e-05	0.00033	CcSEcCtD
Furosemide—Hypersensitivity—Enalapril—coronary artery disease	4.87e-05	0.00033	CcSEcCtD
Furosemide—Body temperature increased—Perindopril—coronary artery disease	4.87e-05	0.00033	CcSEcCtD
Furosemide—Abdominal pain—Perindopril—coronary artery disease	4.87e-05	0.00033	CcSEcCtD
Furosemide—Diarrhoea—Olmesartan—coronary artery disease	4.86e-05	0.00033	CcSEcCtD
Furosemide—Headache—Eplerenone—coronary artery disease	4.86e-05	0.00033	CcSEcCtD
Furosemide—Nervous system disorder—Ramipril—coronary artery disease	4.86e-05	0.000329	CcSEcCtD
Furosemide—Thrombocytopenia—Ramipril—coronary artery disease	4.85e-05	0.000329	CcSEcCtD
Furosemide—Anaphylactic shock—Timolol—coronary artery disease	4.84e-05	0.000328	CcSEcCtD
Furosemide—Pruritus—Pravastatin—coronary artery disease	4.84e-05	0.000328	CcSEcCtD
Furosemide—Nausea—Clopidogrel—coronary artery disease	4.83e-05	0.000328	CcSEcCtD
Furosemide—Skin disorder—Ramipril—coronary artery disease	4.81e-05	0.000326	CcSEcCtD
Furosemide—Vomiting—Simvastatin—coronary artery disease	4.81e-05	0.000326	CcSEcCtD
Furosemide—Hypersensitivity—Telmisartan—coronary artery disease	4.8e-05	0.000326	CcSEcCtD
Furosemide—Nausea—Lovastatin—coronary artery disease	4.8e-05	0.000325	CcSEcCtD
Furosemide—Hyperhidrosis—Ramipril—coronary artery disease	4.79e-05	0.000324	CcSEcCtD
Furosemide—Rash—Simvastatin—coronary artery disease	4.77e-05	0.000323	CcSEcCtD
Furosemide—Dermatitis—Simvastatin—coronary artery disease	4.76e-05	0.000323	CcSEcCtD
Furosemide—Asthenia—Trandolapril—coronary artery disease	4.76e-05	0.000323	CcSEcCtD
Furosemide—Shock—Timolol—coronary artery disease	4.76e-05	0.000323	CcSEcCtD
Furosemide—Feeling abnormal—Losartan—coronary artery disease	4.76e-05	0.000323	CcSEcCtD
Furosemide—Diarrhoea—Niacin—coronary artery disease	4.75e-05	0.000322	CcSEcCtD
Furosemide—Nervous system disorder—Timolol—coronary artery disease	4.75e-05	0.000322	CcSEcCtD
Furosemide—Asthenia—Enalapril—coronary artery disease	4.74e-05	0.000322	CcSEcCtD
Furosemide—Headache—Simvastatin—coronary artery disease	4.74e-05	0.000321	CcSEcCtD
Furosemide—Gastrointestinal pain—Losartan—coronary artery disease	4.72e-05	0.00032	CcSEcCtD
Furosemide—Dizziness—Valsartan—coronary artery disease	4.72e-05	0.00032	CcSEcCtD
Furosemide—Anorexia—Ramipril—coronary artery disease	4.72e-05	0.00032	CcSEcCtD
Furosemide—Nausea—Ezetimibe—coronary artery disease	4.71e-05	0.000319	CcSEcCtD
Furosemide—Skin disorder—Timolol—coronary artery disease	4.7e-05	0.000319	CcSEcCtD
Furosemide—Dizziness—Olmesartan—coronary artery disease	4.7e-05	0.000319	CcSEcCtD
Furosemide—Pruritus—Trandolapril—coronary artery disease	4.7e-05	0.000318	CcSEcCtD
Furosemide—Hyperhidrosis—Timolol—coronary artery disease	4.68e-05	0.000317	CcSEcCtD
Furosemide—Asthenia—Telmisartan—coronary artery disease	4.68e-05	0.000317	CcSEcCtD
Furosemide—Pruritus—Enalapril—coronary artery disease	4.68e-05	0.000317	CcSEcCtD
Furosemide—Diarrhoea—Pravastatin—coronary artery disease	4.68e-05	0.000317	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	4.65e-05	0.000315	CcSEcCtD
Furosemide—Hypotension—Ramipril—coronary artery disease	4.63e-05	0.000314	CcSEcCtD
Furosemide—Anorexia—Timolol—coronary artery disease	4.61e-05	0.000313	CcSEcCtD
Furosemide—Pruritus—Telmisartan—coronary artery disease	4.61e-05	0.000313	CcSEcCtD
Furosemide—Nausea—Eplerenone—coronary artery disease	4.61e-05	0.000312	CcSEcCtD
Furosemide—Dizziness—Niacin—coronary artery disease	4.59e-05	0.000311	CcSEcCtD
Furosemide—Urticaria—Losartan—coronary artery disease	4.59e-05	0.000311	CcSEcCtD
Furosemide—Dry mouth—Lisinopril—coronary artery disease	4.58e-05	0.000311	CcSEcCtD
Furosemide—Body temperature increased—Losartan—coronary artery disease	4.56e-05	0.000309	CcSEcCtD
Furosemide—Abdominal pain—Losartan—coronary artery disease	4.56e-05	0.000309	CcSEcCtD
Furosemide—Asthenia—Captopril—coronary artery disease	4.55e-05	0.000308	CcSEcCtD
Furosemide—Diarrhoea—Trandolapril—coronary artery disease	4.54e-05	0.000308	CcSEcCtD
Furosemide—Vomiting—Valsartan—coronary artery disease	4.54e-05	0.000308	CcSEcCtD
Furosemide—Confusional state—Lisinopril—coronary artery disease	4.53e-05	0.000307	CcSEcCtD
Furosemide—Diarrhoea—Enalapril—coronary artery disease	4.52e-05	0.000307	CcSEcCtD
Furosemide—Hypotension—Timolol—coronary artery disease	4.52e-05	0.000307	CcSEcCtD
Furosemide—Dizziness—Pravastatin—coronary artery disease	4.52e-05	0.000306	CcSEcCtD
Furosemide—Vomiting—Olmesartan—coronary artery disease	4.52e-05	0.000306	CcSEcCtD
Furosemide—Rash—Valsartan—coronary artery disease	4.5e-05	0.000305	CcSEcCtD
Furosemide—Dermatitis—Valsartan—coronary artery disease	4.5e-05	0.000305	CcSEcCtD
Furosemide—Nausea—Simvastatin—coronary artery disease	4.49e-05	0.000304	CcSEcCtD
Furosemide—Anaphylactic shock—Lisinopril—coronary artery disease	4.49e-05	0.000304	CcSEcCtD
Furosemide—Pruritus—Captopril—coronary artery disease	4.49e-05	0.000304	CcSEcCtD
Furosemide—Rash—Olmesartan—coronary artery disease	4.48e-05	0.000304	CcSEcCtD
Furosemide—Dermatitis—Olmesartan—coronary artery disease	4.48e-05	0.000303	CcSEcCtD
Furosemide—Headache—Valsartan—coronary artery disease	4.47e-05	0.000303	CcSEcCtD
Furosemide—Diarrhoea—Telmisartan—coronary artery disease	4.46e-05	0.000302	CcSEcCtD
Furosemide—Headache—Olmesartan—coronary artery disease	4.45e-05	0.000302	CcSEcCtD
Furosemide—Paraesthesia—Ramipril—coronary artery disease	4.45e-05	0.000301	CcSEcCtD
Furosemide—Shock—Lisinopril—coronary artery disease	4.42e-05	0.000299	CcSEcCtD
Furosemide—Asthenia—Perindopril—coronary artery disease	4.42e-05	0.000299	CcSEcCtD
Furosemide—Vomiting—Niacin—coronary artery disease	4.41e-05	0.000299	CcSEcCtD
Furosemide—Somnolence—Ramipril—coronary artery disease	4.4e-05	0.000298	CcSEcCtD
Furosemide—Thrombocytopenia—Lisinopril—coronary artery disease	4.4e-05	0.000298	CcSEcCtD
Furosemide—Dizziness—Trandolapril—coronary artery disease	4.39e-05	0.000298	CcSEcCtD
Furosemide—Rash—Niacin—coronary artery disease	4.38e-05	0.000297	CcSEcCtD
Furosemide—Dermatitis—Niacin—coronary artery disease	4.37e-05	0.000296	CcSEcCtD
Furosemide—Dizziness—Enalapril—coronary artery disease	4.37e-05	0.000296	CcSEcCtD
Furosemide—Skin disorder—Lisinopril—coronary artery disease	4.36e-05	0.000296	CcSEcCtD
Furosemide—Pruritus—Perindopril—coronary artery disease	4.36e-05	0.000295	CcSEcCtD
Furosemide—Headache—Niacin—coronary artery disease	4.35e-05	0.000295	CcSEcCtD
Furosemide—Paraesthesia—Timolol—coronary artery disease	4.35e-05	0.000295	CcSEcCtD
Furosemide—Vomiting—Pravastatin—coronary artery disease	4.35e-05	0.000295	CcSEcCtD
Furosemide—Hyperhidrosis—Lisinopril—coronary artery disease	4.34e-05	0.000294	CcSEcCtD
Furosemide—Diarrhoea—Captopril—coronary artery disease	4.34e-05	0.000294	CcSEcCtD
Furosemide—Dizziness—Telmisartan—coronary artery disease	4.31e-05	0.000292	CcSEcCtD
Furosemide—Rash—Pravastatin—coronary artery disease	4.31e-05	0.000292	CcSEcCtD
Furosemide—Dermatitis—Pravastatin—coronary artery disease	4.31e-05	0.000292	CcSEcCtD
Furosemide—Decreased appetite—Ramipril—coronary artery disease	4.3e-05	0.000292	CcSEcCtD
Furosemide—Somnolence—Timolol—coronary artery disease	4.3e-05	0.000292	CcSEcCtD
Furosemide—Headache—Pravastatin—coronary artery disease	4.28e-05	0.00029	CcSEcCtD
Furosemide—Anorexia—Lisinopril—coronary artery disease	4.28e-05	0.00029	CcSEcCtD
Furosemide—Gastrointestinal disorder—Ramipril—coronary artery disease	4.27e-05	0.00029	CcSEcCtD
Furosemide—Fatigue—Ramipril—coronary artery disease	4.27e-05	0.000289	CcSEcCtD
Furosemide—Hypersensitivity—Losartan—coronary artery disease	4.25e-05	0.000288	CcSEcCtD
Furosemide—Nausea—Valsartan—coronary artery disease	4.24e-05	0.000287	CcSEcCtD
Furosemide—Constipation—Ramipril—coronary artery disease	4.23e-05	0.000287	CcSEcCtD
Furosemide—Nausea—Olmesartan—coronary artery disease	4.22e-05	0.000286	CcSEcCtD
Furosemide—Vomiting—Trandolapril—coronary artery disease	4.22e-05	0.000286	CcSEcCtD
Furosemide—Diarrhoea—Perindopril—coronary artery disease	4.21e-05	0.000286	CcSEcCtD
Furosemide—Decreased appetite—Timolol—coronary artery disease	4.21e-05	0.000285	CcSEcCtD
Furosemide—Vomiting—Enalapril—coronary artery disease	4.2e-05	0.000285	CcSEcCtD
Furosemide—Hypotension—Lisinopril—coronary artery disease	4.2e-05	0.000284	CcSEcCtD
Furosemide—Dizziness—Captopril—coronary artery disease	4.19e-05	0.000284	CcSEcCtD
Furosemide—Rash—Trandolapril—coronary artery disease	4.19e-05	0.000284	CcSEcCtD
Furosemide—Dermatitis—Trandolapril—coronary artery disease	4.18e-05	0.000283	CcSEcCtD
Furosemide—Gastrointestinal disorder—Timolol—coronary artery disease	4.18e-05	0.000283	CcSEcCtD
Furosemide—Fatigue—Timolol—coronary artery disease	4.17e-05	0.000283	CcSEcCtD
Furosemide—Rash—Enalapril—coronary artery disease	4.17e-05	0.000283	CcSEcCtD
Furosemide—Dermatitis—Enalapril—coronary artery disease	4.16e-05	0.000282	CcSEcCtD
Furosemide—Headache—Trandolapril—coronary artery disease	4.16e-05	0.000282	CcSEcCtD
Furosemide—Vomiting—Telmisartan—coronary artery disease	4.15e-05	0.000281	CcSEcCtD
Furosemide—Asthenia—Losartan—coronary artery disease	4.14e-05	0.000281	CcSEcCtD
Furosemide—Headache—Enalapril—coronary artery disease	4.14e-05	0.000281	CcSEcCtD
Furosemide—Pain—Timolol—coronary artery disease	4.14e-05	0.000281	CcSEcCtD
Furosemide—Nausea—Niacin—coronary artery disease	4.12e-05	0.00028	CcSEcCtD
Furosemide—Rash—Telmisartan—coronary artery disease	4.11e-05	0.000279	CcSEcCtD
Furosemide—Dermatitis—Telmisartan—coronary artery disease	4.11e-05	0.000278	CcSEcCtD
Furosemide—Pruritus—Losartan—coronary artery disease	4.09e-05	0.000277	CcSEcCtD
Furosemide—Headache—Telmisartan—coronary artery disease	4.09e-05	0.000277	CcSEcCtD
Furosemide—Feeling abnormal—Ramipril—coronary artery disease	4.08e-05	0.000277	CcSEcCtD
Furosemide—Dizziness—Perindopril—coronary artery disease	4.07e-05	0.000276	CcSEcCtD
Furosemide—Nausea—Pravastatin—coronary artery disease	4.06e-05	0.000275	CcSEcCtD
Furosemide—Gastrointestinal pain—Ramipril—coronary artery disease	4.05e-05	0.000274	CcSEcCtD
Furosemide—Paraesthesia—Lisinopril—coronary artery disease	4.03e-05	0.000273	CcSEcCtD
Furosemide—Vomiting—Captopril—coronary artery disease	4.03e-05	0.000273	CcSEcCtD
Furosemide—Rash—Captopril—coronary artery disease	4e-05	0.000271	CcSEcCtD
Furosemide—Dermatitis—Captopril—coronary artery disease	3.99e-05	0.000271	CcSEcCtD
Furosemide—Somnolence—Lisinopril—coronary artery disease	3.99e-05	0.000271	CcSEcCtD
Furosemide—Feeling abnormal—Timolol—coronary artery disease	3.99e-05	0.00027	CcSEcCtD
Furosemide—Headache—Captopril—coronary artery disease	3.97e-05	0.000269	CcSEcCtD
Furosemide—Gastrointestinal pain—Timolol—coronary artery disease	3.96e-05	0.000268	CcSEcCtD
Furosemide—Diarrhoea—Losartan—coronary artery disease	3.95e-05	0.000268	CcSEcCtD
Furosemide—Nausea—Trandolapril—coronary artery disease	3.94e-05	0.000267	CcSEcCtD
Furosemide—Urticaria—Ramipril—coronary artery disease	3.93e-05	0.000267	CcSEcCtD
Furosemide—Nausea—Enalapril—coronary artery disease	3.93e-05	0.000266	CcSEcCtD
Furosemide—Vomiting—Perindopril—coronary artery disease	3.91e-05	0.000265	CcSEcCtD
Furosemide—Abdominal pain—Ramipril—coronary artery disease	3.91e-05	0.000265	CcSEcCtD
Furosemide—Body temperature increased—Ramipril—coronary artery disease	3.91e-05	0.000265	CcSEcCtD
Furosemide—Decreased appetite—Lisinopril—coronary artery disease	3.9e-05	0.000265	CcSEcCtD
Furosemide—Rash—Perindopril—coronary artery disease	3.88e-05	0.000263	CcSEcCtD
Furosemide—Dermatitis—Perindopril—coronary artery disease	3.88e-05	0.000263	CcSEcCtD
Furosemide—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.88e-05	0.000263	CcSEcCtD
Furosemide—Nausea—Telmisartan—coronary artery disease	3.87e-05	0.000263	CcSEcCtD
Furosemide—Fatigue—Lisinopril—coronary artery disease	3.87e-05	0.000262	CcSEcCtD
Furosemide—Headache—Perindopril—coronary artery disease	3.86e-05	0.000261	CcSEcCtD
Furosemide—Urticaria—Timolol—coronary artery disease	3.85e-05	0.000261	CcSEcCtD
Furosemide—Pain—Lisinopril—coronary artery disease	3.84e-05	0.00026	CcSEcCtD
Furosemide—Constipation—Lisinopril—coronary artery disease	3.84e-05	0.00026	CcSEcCtD
Furosemide—Abdominal pain—Timolol—coronary artery disease	3.83e-05	0.000259	CcSEcCtD
Furosemide—Body temperature increased—Timolol—coronary artery disease	3.83e-05	0.000259	CcSEcCtD
Furosemide—Dizziness—Losartan—coronary artery disease	3.82e-05	0.000259	CcSEcCtD
Furosemide—Nausea—Captopril—coronary artery disease	3.77e-05	0.000255	CcSEcCtD
Furosemide—Feeling abnormal—Lisinopril—coronary artery disease	3.7e-05	0.000251	CcSEcCtD
Furosemide—Gastrointestinal pain—Lisinopril—coronary artery disease	3.67e-05	0.000249	CcSEcCtD
Furosemide—Vomiting—Losartan—coronary artery disease	3.67e-05	0.000249	CcSEcCtD
Furosemide—Nausea—Perindopril—coronary artery disease	3.66e-05	0.000248	CcSEcCtD
Furosemide—Hypersensitivity—Ramipril—coronary artery disease	3.65e-05	0.000247	CcSEcCtD
Furosemide—Rash—Losartan—coronary artery disease	3.64e-05	0.000247	CcSEcCtD
Furosemide—Dermatitis—Losartan—coronary artery disease	3.64e-05	0.000247	CcSEcCtD
Furosemide—Headache—Losartan—coronary artery disease	3.62e-05	0.000245	CcSEcCtD
Furosemide—Urticaria—Lisinopril—coronary artery disease	3.57e-05	0.000242	CcSEcCtD
Furosemide—Hypersensitivity—Timolol—coronary artery disease	3.57e-05	0.000242	CcSEcCtD
Furosemide—Asthenia—Ramipril—coronary artery disease	3.55e-05	0.000241	CcSEcCtD
Furosemide—Abdominal pain—Lisinopril—coronary artery disease	3.55e-05	0.000241	CcSEcCtD
Furosemide—Body temperature increased—Lisinopril—coronary artery disease	3.55e-05	0.000241	CcSEcCtD
Furosemide—Pruritus—Ramipril—coronary artery disease	3.5e-05	0.000237	CcSEcCtD
Furosemide—Asthenia—Timolol—coronary artery disease	3.47e-05	0.000235	CcSEcCtD
Furosemide—Nausea—Losartan—coronary artery disease	3.43e-05	0.000233	CcSEcCtD
Furosemide—Pruritus—Timolol—coronary artery disease	3.42e-05	0.000232	CcSEcCtD
Furosemide—Diarrhoea—Ramipril—coronary artery disease	3.39e-05	0.00023	CcSEcCtD
Furosemide—Diarrhoea—Timolol—coronary artery disease	3.31e-05	0.000225	CcSEcCtD
Furosemide—Hypersensitivity—Lisinopril—coronary artery disease	3.31e-05	0.000224	CcSEcCtD
Furosemide—Dizziness—Ramipril—coronary artery disease	3.27e-05	0.000222	CcSEcCtD
Furosemide—Asthenia—Lisinopril—coronary artery disease	3.22e-05	0.000218	CcSEcCtD
Furosemide—Dizziness—Timolol—coronary artery disease	3.2e-05	0.000217	CcSEcCtD
Furosemide—Pruritus—Lisinopril—coronary artery disease	3.18e-05	0.000215	CcSEcCtD
Furosemide—Vomiting—Ramipril—coronary artery disease	3.15e-05	0.000213	CcSEcCtD
Furosemide—Rash—Ramipril—coronary artery disease	3.12e-05	0.000212	CcSEcCtD
Furosemide—Dermatitis—Ramipril—coronary artery disease	3.12e-05	0.000211	CcSEcCtD
Furosemide—Headache—Ramipril—coronary artery disease	3.1e-05	0.00021	CcSEcCtD
Furosemide—Vomiting—Timolol—coronary artery disease	3.08e-05	0.000209	CcSEcCtD
Furosemide—Diarrhoea—Lisinopril—coronary artery disease	3.07e-05	0.000208	CcSEcCtD
Furosemide—Rash—Timolol—coronary artery disease	3.05e-05	0.000207	CcSEcCtD
Furosemide—Dermatitis—Timolol—coronary artery disease	3.05e-05	0.000207	CcSEcCtD
Furosemide—Headache—Timolol—coronary artery disease	3.03e-05	0.000206	CcSEcCtD
Furosemide—Dizziness—Lisinopril—coronary artery disease	2.97e-05	0.000201	CcSEcCtD
Furosemide—Nausea—Ramipril—coronary artery disease	2.94e-05	0.000199	CcSEcCtD
Furosemide—Nausea—Timolol—coronary artery disease	2.88e-05	0.000195	CcSEcCtD
Furosemide—Vomiting—Lisinopril—coronary artery disease	2.86e-05	0.000194	CcSEcCtD
Furosemide—Rash—Lisinopril—coronary artery disease	2.83e-05	0.000192	CcSEcCtD
Furosemide—Dermatitis—Lisinopril—coronary artery disease	2.83e-05	0.000192	CcSEcCtD
Furosemide—Headache—Lisinopril—coronary artery disease	2.81e-05	0.000191	CcSEcCtD
Furosemide—Nausea—Lisinopril—coronary artery disease	2.67e-05	0.000181	CcSEcCtD
Furosemide—CA12—Metabolism—POMC—coronary artery disease	6.43e-06	7.36e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—MTHFR—coronary artery disease	6.41e-06	7.34e-05	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—coronary artery disease	6.41e-06	7.34e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPP2CA—coronary artery disease	6.4e-06	7.33e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—GPX1—coronary artery disease	6.38e-06	7.31e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTP1—coronary artery disease	6.38e-06	7.3e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	6.37e-06	7.29e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—coronary artery disease	6.33e-06	7.24e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—coronary artery disease	6.33e-06	7.24e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARGC1A—coronary artery disease	6.32e-06	7.24e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	6.3e-06	7.21e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—HMOX1—coronary artery disease	6.29e-06	7.2e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	6.28e-06	7.19e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—NOS3—coronary artery disease	6.25e-06	7.16e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—CD36—coronary artery disease	6.22e-06	7.12e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAT—coronary artery disease	6.21e-06	7.11e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—UGCG—coronary artery disease	6.18e-06	7.07e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPAT—coronary artery disease	6.18e-06	7.07e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—MDH2—coronary artery disease	6.18e-06	7.07e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLCD1—coronary artery disease	6.18e-06	7.07e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAT—coronary artery disease	6.16e-06	7.06e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TIMP1—coronary artery disease	6.16e-06	7.06e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—MTHFR—coronary artery disease	6.14e-06	7.04e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPP2CA—coronary artery disease	6.14e-06	7.03e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	6.13e-06	7.02e-05	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—APOA1—coronary artery disease	6.11e-06	6.99e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AGT—coronary artery disease	6.09e-06	6.97e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—coronary artery disease	6.08e-06	6.97e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CETP—coronary artery disease	6.06e-06	6.93e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NOS3—coronary artery disease	6.05e-06	6.93e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—NOS3—coronary artery disease	6.05e-06	6.93e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOB—coronary artery disease	6.02e-06	6.9e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—coronary artery disease	5.97e-06	6.83e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PGM1—coronary artery disease	5.95e-06	6.81e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF1—coronary artery disease	5.95e-06	6.81e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—coronary artery disease	5.93e-06	6.79e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—coronary artery disease	5.93e-06	6.79e-05	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—APOA1—coronary artery disease	5.91e-06	6.77e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOA1—coronary artery disease	5.9e-06	6.76e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—MTHFR—coronary artery disease	5.89e-06	6.75e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTM1—coronary artery disease	5.86e-06	6.71e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—coronary artery disease	5.86e-06	6.71e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AGT—coronary artery disease	5.84e-06	6.69e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	5.81e-06	6.66e-05	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—coronary artery disease	5.8e-06	6.64e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	5.76e-06	6.6e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—LPL—coronary artery disease	5.75e-06	6.59e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PYGB—coronary artery disease	5.74e-06	6.58e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CKB—coronary artery disease	5.74e-06	6.58e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.74e-06	6.57e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—coronary artery disease	5.72e-06	6.55e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—coronary artery disease	5.72e-06	6.55e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOA1—coronary artery disease	5.66e-06	6.48e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SERPINE1—coronary artery disease	5.65e-06	6.47e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—GPX1—coronary artery disease	5.61e-06	6.43e-05	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—coronary artery disease	5.61e-06	6.43e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—NOS3—coronary artery disease	5.61e-06	6.42e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AGT—coronary artery disease	5.6e-06	6.41e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—coronary artery disease	5.53e-06	6.34e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—coronary artery disease	5.53e-06	6.34e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—coronary artery disease	5.48e-06	6.28e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CD36—coronary artery disease	5.47e-06	6.26e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGAV—coronary artery disease	5.43e-06	6.22e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOA1—coronary artery disease	5.42e-06	6.21e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KNG1—coronary artery disease	5.41e-06	6.2e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLIN1—coronary artery disease	5.4e-06	6.18e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PFKFB3—coronary artery disease	5.4e-06	6.18e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTM2—coronary artery disease	5.4e-06	6.18e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—DLAT—coronary artery disease	5.4e-06	6.18e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—COX5B—coronary artery disease	5.4e-06	6.18e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPP2CA—coronary artery disease	5.4e-06	6.18e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAUR—coronary artery disease	5.36e-06	6.14e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PLAT—coronary artery disease	5.34e-06	6.11e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNA2—coronary artery disease	5.3e-06	6.07e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLG—coronary artery disease	5.24e-06	6e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—JAK2—coronary artery disease	5.24e-06	6e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARG—coronary artery disease	5.2e-06	5.95e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—MTHFR—coronary artery disease	5.18e-06	5.93e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	5.13e-06	5.88e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—coronary artery disease	5.13e-06	5.87e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—POMC—coronary artery disease	5.13e-06	5.87e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SULT1E1—coronary artery disease	5.12e-06	5.86e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PRKCE—coronary artery disease	5.04e-06	5.77e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SOD1—coronary artery disease	5.03e-06	5.76e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARG—coronary artery disease	4.98e-06	5.71e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	4.97e-06	5.69e-05	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—coronary artery disease	4.94e-06	5.65e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AGT—coronary artery disease	4.92e-06	5.64e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—POMC—coronary artery disease	4.91e-06	5.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKR1B1—coronary artery disease	4.88e-06	5.59e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HK2—coronary artery disease	4.88e-06	5.59e-05	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK1—coronary artery disease	4.84e-06	5.55e-05	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—coronary artery disease	4.84e-06	5.54e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—coronary artery disease	4.82e-06	5.52e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARG—coronary artery disease	4.78e-06	5.47e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOA1—coronary artery disease	4.77e-06	5.46e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—POMC—coronary artery disease	4.71e-06	5.4e-05	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—coronary artery disease	4.69e-06	5.37e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC27A1—coronary artery disease	4.68e-06	5.36e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—coronary artery disease	4.67e-06	5.35e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOB—coronary artery disease	4.63e-06	5.31e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CPT1B—coronary artery disease	4.59e-06	5.26e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LCAT—coronary artery disease	4.59e-06	5.26e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PLG—coronary artery disease	4.54e-06	5.2e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HGF—coronary artery disease	4.51e-06	5.16e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA4—coronary artery disease	4.51e-06	5.16e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—coronary artery disease	4.48e-06	5.13e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—NOS3—coronary artery disease	4.47e-06	5.12e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CSF2—coronary artery disease	4.46e-06	5.1e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	4.42e-06	5.07e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCLM—coronary artery disease	4.35e-06	4.98e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PDHA1—coronary artery disease	4.35e-06	4.98e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—coronary artery disease	4.3e-06	4.92e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—NOS3—coronary artery disease	4.29e-06	4.91e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGB3—coronary artery disease	4.27e-06	4.89e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	4.22e-06	4.83e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP11B2—coronary artery disease	4.21e-06	4.83e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—TXNRD1—coronary artery disease	4.21e-06	4.83e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD36—coronary artery disease	4.2e-06	4.81e-05	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CA—coronary artery disease	4.2e-06	4.81e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARG—coronary artery disease	4.2e-06	4.81e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.19e-06	4.8e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC22A3—coronary artery disease	4.15e-06	4.75e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PPP2CA—coronary artery disease	4.15e-06	4.75e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—POMC—coronary artery disease	4.14e-06	4.74e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—NOS3—coronary artery disease	4.11e-06	4.71e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ARNTL—coronary artery disease	4.09e-06	4.69e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HADH—coronary artery disease	4.09e-06	4.69e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—coronary artery disease	4.09e-06	4.68e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PRKCD—coronary artery disease	4.08e-06	4.67e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	4.03e-06	4.61e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOB—coronary artery disease	4.01e-06	4.59e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	3.93e-06	4.5e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—coronary artery disease	3.92e-06	4.49e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—coronary artery disease	3.88e-06	4.45e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA2—coronary artery disease	3.88e-06	4.44e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX2—coronary artery disease	3.88e-06	4.44e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLA2G2A—coronary artery disease	3.88e-06	4.44e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MMP1—coronary artery disease	3.83e-06	4.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX4—coronary artery disease	3.83e-06	4.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCG5—coronary artery disease	3.83e-06	4.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SULT1A1—coronary artery disease	3.83e-06	4.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HK1—coronary artery disease	3.83e-06	4.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	3.83e-06	4.38e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HADHA—coronary artery disease	3.79e-06	4.34e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—coronary artery disease	3.78e-06	4.32e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAU—coronary artery disease	3.76e-06	4.31e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—coronary artery disease	3.76e-06	4.3e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CA—coronary artery disease	3.74e-06	4.29e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTA1—coronary artery disease	3.74e-06	4.29e-05	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—coronary artery disease	3.72e-06	4.26e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPA—coronary artery disease	3.7e-06	4.24e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOA1—coronary artery disease	3.67e-06	4.2e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CA—coronary artery disease	3.65e-06	4.18e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CA—coronary artery disease	3.65e-06	4.18e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—NOS3—coronary artery disease	3.61e-06	4.14e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK14—coronary artery disease	3.61e-06	4.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLCB3—coronary artery disease	3.58e-06	4.1e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—coronary artery disease	3.56e-06	4.08e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA5—coronary artery disease	3.55e-06	4.06e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CA—coronary artery disease	3.52e-06	4.03e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—F2—coronary artery disease	3.5e-06	4.01e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—FN1—coronary artery disease	3.5e-06	4.01e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK1—coronary artery disease	3.5e-06	4e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—P4HB—coronary artery disease	3.48e-06	3.98e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS2—coronary artery disease	3.46e-06	3.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	3.45e-06	3.95e-05	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—coronary artery disease	3.43e-06	3.93e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLA2G1B—coronary artery disease	3.41e-06	3.91e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CA—coronary artery disease	3.4e-06	3.9e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CA—coronary artery disease	3.4e-06	3.9e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.38e-06	3.87e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.34e-06	3.82e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—coronary artery disease	3.3e-06	3.78e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—VCAN—coronary artery disease	3.22e-06	3.69e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALDOA—coronary artery disease	3.19e-06	3.66e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.17e-06	3.63e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CA—coronary artery disease	3.15e-06	3.61e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—DCN—coronary artery disease	3.1e-06	3.55e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—coronary artery disease	3.06e-06	3.51e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—coronary artery disease	3.06e-06	3.5e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	3.03e-06	3.47e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALDH2—coronary artery disease	3.02e-06	3.45e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—coronary artery disease	2.98e-06	3.41e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—coronary artery disease	2.98e-06	3.41e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.94e-06	3.37e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LIPC—coronary artery disease	2.94e-06	3.37e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HBA1—coronary artery disease	2.94e-06	3.37e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3C2A—coronary artery disease	2.94e-06	3.37e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2C19—coronary artery disease	2.94e-06	3.37e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOC3—coronary artery disease	2.92e-06	3.35e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SERPINE1—coronary artery disease	2.91e-06	3.33e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LDLR—coronary artery disease	2.9e-06	3.33e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.9e-06	3.32e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—coronary artery disease	2.87e-06	3.29e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTT1—coronary artery disease	2.87e-06	3.29e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC9A1—coronary artery disease	2.87e-06	3.29e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCLC—coronary artery disease	2.84e-06	3.25e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CETP—coronary artery disease	2.84e-06	3.25e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SDC1—coronary artery disease	2.8e-06	3.21e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—coronary artery disease	2.78e-06	3.19e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—coronary artery disease	2.78e-06	3.19e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS3—coronary artery disease	2.78e-06	3.18e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—JAK2—coronary artery disease	2.7e-06	3.09e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PSMB5—coronary artery disease	2.65e-06	3.03e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PSMA6—coronary artery disease	2.65e-06	3.03e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CTGF—coronary artery disease	2.59e-06	2.96e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—coronary artery disease	2.58e-06	2.95e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMGCR—coronary artery disease	2.56e-06	2.94e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GOT2—coronary artery disease	2.56e-06	2.94e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CA—coronary artery disease	2.52e-06	2.88e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	2.48e-06	2.84e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CA—coronary artery disease	2.41e-06	2.76e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLCB1—coronary artery disease	2.36e-06	2.7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.31e-06	2.65e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CA—coronary artery disease	2.31e-06	2.65e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCA1—coronary artery disease	2.29e-06	2.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GGT1—coronary artery disease	2.21e-06	2.54e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GOT1—coronary artery disease	2.21e-06	2.54e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—coronary artery disease	2.05e-06	2.35e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CA—coronary artery disease	2.03e-06	2.33e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—coronary artery disease	2e-06	2.29e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTP1—coronary artery disease	1.99e-06	2.28e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARGC1A—coronary artery disease	1.97e-06	2.26e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—coronary artery disease	1.97e-06	2.26e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMOX1—coronary artery disease	1.96e-06	2.25e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAT—coronary artery disease	1.94e-06	2.22e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—coronary artery disease	1.89e-06	2.16e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOB—coronary artery disease	1.88e-06	2.15e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—coronary artery disease	1.84e-06	2.1e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTM1—coronary artery disease	1.83e-06	2.09e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK1—coronary artery disease	1.8e-06	2.06e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPL—coronary artery disease	1.79e-06	2.05e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX1—coronary artery disease	1.75e-06	2e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CD36—coronary artery disease	1.7e-06	1.95e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPP2CA—coronary artery disease	1.68e-06	1.93e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—coronary artery disease	1.66e-06	1.9e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTHFR—coronary artery disease	1.62e-06	1.85e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CA—coronary artery disease	1.56e-06	1.79e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AGT—coronary artery disease	1.53e-06	1.76e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—coronary artery disease	1.5e-06	1.72e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA1—coronary artery disease	1.49e-06	1.7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.42e-06	1.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARG—coronary artery disease	1.31e-06	1.5e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—POMC—coronary artery disease	1.29e-06	1.48e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—coronary artery disease	1.28e-06	1.46e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NOS3—coronary artery disease	1.13e-06	1.29e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—coronary artery disease	1.03e-06	1.18e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CA—coronary artery disease	6.34e-07	7.26e-06	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—coronary artery disease	5.18e-07	5.93e-06	CbGpPWpGaD
